These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 31486583)

  • 21. Technology outlook for real-time quality attribute and process parameter monitoring in biopharmaceutical development-A review.
    Wasalathanthri DP; Rehmann MS; Song Y; Gu Y; Mi L; Shao C; Chemmalil L; Lee J; Ghose S; Borys MC; Ding J; Li ZJ
    Biotechnol Bioeng; 2020 Oct; 117(10):3182-3198. PubMed ID: 32946122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mathematical modeling and process analytical technology for continuous chromatography of biopharmaceutical products.
    Khanal O
    Curr Opin Biotechnol; 2022 Dec; 78():102796. PubMed ID: 36152423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biopharmaceuticals in China.
    Hu X; Ma Q; Zhang S
    Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conference scene: recent advancements in microscale bioprocess development.
    Guy H
    Immunotherapy; 2012 Feb; 4(2):145-7. PubMed ID: 22339457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbial technologies for biotherapeutics production: Key tools for advanced biopharmaceutical process development and control.
    Zalai D; Kopp J; Kozma B; Küchler M; Herwig C; Kager J
    Drug Discov Today Technol; 2020 Dec; 38():9-24. PubMed ID: 34895644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specifications from a biotechnology industry perspective.
    Garnick RL
    Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality-by-design for biotechnology-related pharmaceuticals.
    Mandenius CF; Graumann K; Schultz TW; Premstaller A; Olsson IM; Petiot E; Clemens C; Welin M
    Biotechnol J; 2009 May; 4(5):600-9. PubMed ID: 19418475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Product Development, Manufacturing, and Packaging of Solid Dosage Forms Under QbD and PAT Paradigm: DOE Case Studies for Industrial Applications.
    Singh BN
    AAPS PharmSciTech; 2019 Sep; 20(8):313. PubMed ID: 31529232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations for Enhancing Quality and Capability of Indian Biopharmaceutical Industry: Summary of a Workshop.
    Uppal A; Koduri CK; Yadlapalli S; Chirmule N; Chakrabarti R; Atouf F
    J Pharm Sci; 2020 Oct; 109(10):2958-2961. PubMed ID: 32710904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.
    Närhi M; Nordström K
    Eur J Pharm Biopharm; 2005 Apr; 59(3):397-405. PubMed ID: 15760720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput process development for biopharmaceutical drug substances.
    Bhambure R; Kumar K; Rathore AS
    Trends Biotechnol; 2011 Mar; 29(3):127-35. PubMed ID: 21255855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposable bioprocessing: the future has arrived.
    Rao G; Moreira A; Brorson K
    Biotechnol Bioeng; 2009 Feb; 102(2):348-56. PubMed ID: 19090536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality cell therapy manufacturing by design.
    Lipsitz YY; Timmins NE; Zandstra PW
    Nat Biotechnol; 2016 Apr; 34(4):393-400. PubMed ID: 27054995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large scale demonstration of a process analytical technology application in bioprocessing: use of on-line high performance liquid chromatography for making real time pooling decisions for process chromatography.
    Rathore AS; Parr L; Dermawan S; Lawson K; Lu Y
    Biotechnol Prog; 2010; 26(2):448-57. PubMed ID: 19927320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and establishment of specifications for biopharmaceuticals.
    Davis GC; Riggin RM
    Dev Biol Stand; 1997; 91():49-54. PubMed ID: 9413683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Intercompany Perspective on Biopharmaceutical Drug Product Robustness Studies.
    Morar-Mitrica S; Adams ML; Crotts G; Wurth C; Ihnat PM; Tabish T; Antochshuk V; DiLuzio W; Dix DB; Fernandez JE; Gupta K; Fleming MS; He B; Kranz JK; Liu D; Narasimhan C; Routhier E; Taylor KD; Truong N; Stokes ESE
    J Pharm Sci; 2018 Feb; 107(2):529-542. PubMed ID: 29074375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosimilars advancements: Moving on to the future.
    Tsuruta LR; Lopes dos Santos M; Moro AM
    Biotechnol Prog; 2015; 31(5):1139-49. PubMed ID: 25708573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.